CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia

Annals of Neurology

Volumn 66, Issue 4, 2009, Pages 521-531

  Berrih Aknin, Sonia ^a,b   Ruhlmann, Nathalie ^a,b   Bismuth, Jacky ^a,b   Cizeron Clairac, Géraldine ^a,b   Zelman, Einat ^c   Shachar, Idit ^c   Dartevelle, Philippe ^a   De Rosbo, Nicole Kerlero ^a,b   Le Panse, Rozen ^a,b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CORTICOSTEROID; CXCL13 CHEMOKINE; INTERLEUKIN 2 RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTOME;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; B LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GENE OVEREXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOCOMPETENT CELL; INFANT; LASER CAPTURE MICRODISSECTION; LYMPH VESSEL; LYMPHANGIOGENESIS; MYASTHENIA GRAVIS; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYMUS HYPERPLASIA; VASCULAR ENDOTHELIUM; VENULE;

ADOLESCENT; ADULT; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CHEMOKINE CCL21; CHEMOTAXIS, LEUKOCYTE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; LYMPHATIC VESSELS; MYASTHENIA GRAVIS; THYMUS HYPERPLASIA; YOUNG ADULT;

EID: 70449371659     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21628     Document Type: Article

References (38)

1. Aharonov A, Abramsky O, Tarrab-Hazdai R, Fuchs S. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet 1975;2:340-342.
2. Berrih-Aknin S, Morel E, Raimond F, et al. The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann N Y Acad Sci 1987;505:50-70. (Pubitemid 18146142)
3. Kuks JB, Oosterhuis HJ, Limburg PC, The TH. Antiacetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis: clinical correlations. J Autoimmun 1991;4:197-211.
4. Wakkach A, Guyon T, Bruand C, et al. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J Immunol 1996;157:3752-3760. (Pubitemid 126449193)
5. Leprince C, Cohen-Kaminsky S, Berrih-Aknin S, et al. Thymic B cells from myasthenia gravis patients are activated B cells: phenotypic and functional analysis. J Immunol 1990;145:2115-2122. (Pubitemid 20343374)
6. Melms A, Schalke BC, Kirchner T, et al. Thymus in myasthenia gravis: isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest 1988;81:902-908. (Pubitemid 18079743)
7. Le Panse R, Cizeron-Clairac G, Bismuth J, Berrih Aknin S. Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative Myasthenia Gravis patients and the role of CCL21 in thymic hyperplasia. J Immunol 2006;177:7868-7879. (Pubitemid 44846302)
8. Annunziato F, Romagnani P, Cosmi L, et al. Chemokines and lymphopoiesis in human thymus. Trends Immunol 2001;22:277-281.
9. Liu C, Ueno T, Kuse S, et al. The role of CCL21 in recruitment of T-precursor cells to fetal thymi. Blood 2005;105:31-39. (Pubitemid 40053060)
10. Ueno T, Hara K, Willis MS, et al. Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity 2002;16:205-218. (Pubitemid 34211961)
11. Gunn MD, Tangemann K, Tam C, et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 1998;95:258-263. (Pubitemid 28103941)
12. Gunn MD, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-460. (Pubitemid 29187367)
13. Flaishon L, Lantner F, Hershkoviz R, et al. Low levels of IFN-gamma down-regulate the integrin-dependent adhesion of B cells by activating a pathway that interferes with cytoskeleton rearrangement. J Biol Chem 2001;276:46701-46706. (Pubitemid 37373034)
14. Meraouna A, Cizeron-Clairac G, Le Panse R, et al. The chemokine CXCL13 is a key molecule in autoimmune Myasthenia Gravis. Blood 2006;108:432-440. (Pubitemid 44061339)
15. Poëa-Guyon S, Christadoss P, Le Panse R, et al. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J Immunol 2005;174:5941-5949. (Pubitemid 40663780)
16. Berrih-Aknin S, Cohen-Kaminsky S, Truffault F. T-cell receptor expression in the thymus from patients with myasthenia gravis. Ann N Y Acad Sci 1995;756:438-440.
17. Davalos-Misslitz AC, Rieckenberg J, Willenzon S, et al. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur J Immunol 2007;37:613-622. (Pubitemid 46916929)
18. Feferman T, Maiti PK, Berrih-Aknin S, et al. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. J Immunol 2005;174:5324-5331. (Pubitemid 40598086)
19. Saito R, Onodera H, Tago H, et al. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients. J Neuroimmunol 2005;170:172-178. (Pubitemid 41740917)
20. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712. (Pubitemid 129515761)
21. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998;188:1679-1689. (Pubitemid 28516113)
22. Onodera H. The role of the thymus in the pathogenesis of myasthenia gravis. Tohoku J Exp Med 2005;207:87-98. (Pubitemid 41601023)
23. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-457.
24. Odaka C, Morisada T, Oike Y, Suda T. Distribution of lymphatic vessels in mouse thymus: immunofluorescence analysis. Cell Tissue Res 2006;325:13-22. (Pubitemid 44124294)
25. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. Embo J 2002;21:1505-1513. (Pubitemid 34614607)
26. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158:867-877. (Pubitemid 32221780)
27. Barone F, Bombardieri M, Manzo A, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005;52:1773-1784. (Pubitemid 40852886)
28. Takemura S, Braun A, Crowson C, et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001;167:1072-1080.
29. Fan L, Reilly CR, Luo Y, et al. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 2000;164:3955-3959. (Pubitemid 30215047)
30. Martin AP, Coronel EC, Sano G, et al. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J Immunol 2004;173:4791-4798. (Pubitemid 39387758)
31. Hopken UE, Wengner AM, Loddenkemper C, et al. CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity. Blood 2007;109:886-895. (Pubitemid 46220631)
32. Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005;106:444-446.
33. Manzo A, Bugatti S, Caporali R, et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol 2007;171:1549-1562. (Pubitemid 350158316)
34. Angeli V, Ginhoux F, Llodra J, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006;24:203-215. (Pubitemid 43214589)
35. Furtado GC, Marinkovic T, Martin AP, et al. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc Natl Acad Sci U S A 2007;104:5026-5031. (Pubitemid 47186170)
36. Pearse G. Normal structure, function and histology of the thymus. Toxicol Pathol 2006;34:504-514. (Pubitemid 44652215)
37. Nagane Y, Utsugisawa K, Obara D, et al. Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis. Muscle Nerve 2003;27:582-589. (Pubitemid 36523517)
38. Debes GF, Arnold CN, Young AJ, et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 2005;6:889-894.